Compile Data Set for Download or QSAR
Report error Found 59 of ic50 for UniProtKB: P78368
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM130909(US8822500, Stauro- sporine | US9920060, Staurospor...)
Affinity DataIC50: 2nMAssay Description:Inhibition of human CK1g2 using KRRRAL[pS]VASLPGL as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400754(CHEMBL2203564)
Affinity DataIC50: 3nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400756(CHEMBL2203562)
Affinity DataIC50: 3nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400753(CHEMBL2203565)
Affinity DataIC50: 4nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform alpha/delta/epsilon/gamma-1/gamma-2(Human)
Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre

Curated by ChEMBL
LigandPNGBDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Affinity DataIC50: 4nMAssay Description:Inhibition of CK1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400755(CHEMBL2203563)
Affinity DataIC50: 5nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400757(CHEMBL2203561)
Affinity DataIC50: 5nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400748(CHEMBL2203556)
Affinity DataIC50: 8nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400752(CHEMBL2203552)
Affinity DataIC50: 8nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400750(CHEMBL2203554)
Affinity DataIC50: 17nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400745(CHEMBL2203559)
Affinity DataIC50: 24nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400744(CHEMBL2203560)
Affinity DataIC50: 26nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400749(CHEMBL2203555)
Affinity DataIC50: 33nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400753(CHEMBL2203565)
Affinity DataIC50: 44nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400751(CHEMBL2203553)
Affinity DataIC50: 50nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400747(CHEMBL2203557)
Affinity DataIC50: 80nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400753(CHEMBL2203565)
Affinity DataIC50: 87nMAssay Description:Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400755(CHEMBL2203563)
Affinity DataIC50: 200nMAssay Description:Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform alpha/delta/epsilon/gamma-1/gamma-2(Human)
Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre

Curated by ChEMBL
LigandPNGBDBM50587013(CHEMBL5091216)
Affinity DataIC50: 230nMAssay Description:Inhibition of CK1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400755(CHEMBL2203563)
Affinity DataIC50: 254nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform alpha/delta/epsilon/gamma-1/gamma-2(Human)
Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre

Curated by ChEMBL
LigandPNGBDBM50229971(4-[4-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-pyridin...)
Affinity DataIC50: 300nMAssay Description:Inhibition of human CK1 in presence of [gamma33P]-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400752(CHEMBL2203552)
Affinity DataIC50: 348nMAssay Description:Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400756(CHEMBL2203562)
Affinity DataIC50: 394nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400754(CHEMBL2203564)
Affinity DataIC50: 537nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400757(CHEMBL2203561)
Affinity DataIC50: 584nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50390500(CHEMBL2071614)
Affinity DataIC50: 700nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400744(CHEMBL2203560)
Affinity DataIC50: 840nMAssay Description:Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400746(CHEMBL2203558)
Affinity DataIC50: 853nMAssay Description:Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50311017(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyri...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of CSNK1G2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM174948(US9096593, P-2049)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of CSNK1G2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50390496(CHEMBL2071610)
Affinity DataIC50: 1.17E+3nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400744(CHEMBL2203560)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 1.37E+3nMAssay Description:Inhibition of human CK1gamma2 using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details Article
PubMed
TargetCasein kinase I isoform alpha/delta/epsilon/gamma-1/gamma-2(Human)
Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of Casein kinase IMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50390497(CHEMBL2071611)
Affinity DataIC50: 1.45E+3nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50390498(CHEMBL2071612)
Affinity DataIC50: 1.51E+3nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50390503(CHEMBL2071618)
Affinity DataIC50: 2.34E+3nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform alpha/delta/epsilon/gamma-1/gamma-2(Human)
Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre

Curated by ChEMBL
LigandPNGBDBM50169892(3-{4-[4-(3-Chloro-phenylamino)-[1,3,5]triazin-2-yl...)
Affinity DataIC50: 3.05E+3nMAssay Description:Inhibition of Casein kinase IMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 3.07E+3nMAssay Description:Inhibition of human CK1gamma2 using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50400752(CHEMBL2203552)
Affinity DataIC50: 3.33E+3nMAssay Description:Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50390506(CHEMBL2071624)
Affinity DataIC50: 3.83E+3nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50390499(CHEMBL2071613)
Affinity DataIC50: 4.54E+3nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50390495(CHEMBL2071609)
Affinity DataIC50: 4.89E+3nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM124350(CHEMBL2071607 | US8759532, 1)
Affinity DataIC50: 6.56E+3nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50528817(CHEMBL4462530 | US10717746, Example 14 | US2023041...)
Affinity DataIC50: 6.66E+3nMAssay Description:Inhibition of CK1gamma2 (unknown origin) in presence of 5 mM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2022
Entry Details Article
PubMed
TargetCasein kinase I isoform alpha/delta/epsilon/gamma-1/gamma-2(Human)
Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 7.20E+3nMAssay Description:Inhibitory activity against Casein Kinase 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50390507(CHEMBL2071625)
Affinity DataIC50: 9.10E+3nMAssay Description:Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblottingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform alpha/delta/epsilon/gamma-1/gamma-2(Human)
Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre

Curated by ChEMBL
LigandPNGBDBM92674(Isoquinolinesulfonamide, CKI-7)
Affinity DataIC50: 9.50E+3nMAssay Description:Inhibition of CK1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM103727(US8563545, 1 | US10112907, Example 00033 | US10206...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CSNK1G2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetCasein kinase I isoform gamma-2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50135286(CHEMBL3745885)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CK1gamma2 using [KRRRAL[pS]VASLPGL] as substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2017
Entry Details Article
PubMed
Displayed 1 to 50 (of 59 total ) | Next | Last >>
Jump to: